Mortality in the Highly Active Antiretroviral Therapy Era, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.43, issue.1, pp.27-34, 2006. ,
DOI : 10.1097/01.qai.0000233310.90484.16
Coronary Heart Disease in HIV-Infected Individuals, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.33, issue.4, pp.506-512, 2003. ,
DOI : 10.1097/00126334-200308010-00012
Risk Factors for Coronary Heart Disease in Patients Treated for Human Immunodeficiency Virus Infection Compared with the General Population, Clinical Infectious Diseases, vol.37, issue.2, pp.292-298, 2003. ,
DOI : 10.1086/375844
Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study, HIV Medicine, vol.126, issue.1, pp.1-10, 2003. ,
DOI : 10.1001/jama.285.19.2486
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study, HIV Medicine, vol.10, issue.1, pp.404-414, 2006. ,
DOI : 10.1046/j.1468-1293.2003.00138.x
Cardiovascular disease risk factors in HIV patients ??? association with antiretroviral therapy. Results from the DAD study, AIDS, vol.17, issue.8, pp.1179-93, 2003. ,
DOI : 10.1097/00002030-200305230-00010
Cholesterol Lowering in the Management of Coronary Artery Disease: The Clinical Implications of Recent Trials, The American Journal of Medicine, vol.104, issue.2, pp.2-5, 1998. ,
DOI : 10.1016/S0002-9343(98)00038-2
Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement, Annals of Medicine, vol.34, issue.1, pp.55-63, 2002. ,
DOI : 10.1080/078538902317338652
Progression of Atherosclerosis as Assessed by Carotid Intima-Media Thickness in Patients With HIV Infection, Circulation, vol.109, issue.13, pp.1603-1611, 2004. ,
DOI : 10.1161/01.CIR.0000124480.32233.8A
Carotid intima?media thickness in HIV patients treated with antiretroviral therapy, Clinical Physiology and Functional Imaging, vol.19, issue.3, pp.173-182, 2007. ,
DOI : 10.1016/0140-6736(92)92270-P
Progression of carotid artery intima???media thickening in HIV-infected and uninfected adults, AIDS, vol.21, issue.9, pp.1137-1182, 2007. ,
DOI : 10.1097/QAD.0b013e32811ebf79
Combination antiretroviral therapy and the risk of myocardial infarction, N Engl J Med, vol.349, pp.1993-2003, 2003. ,
Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men, AIDS, vol.17, issue.17, pp.2479-2486, 2003. ,
DOI : 10.1097/00002030-200311210-00010
Subclinical Carotid Atherosclerosis in HIV-Infected Patients: Role of Combination Antiretroviral Therapy, Stroke, vol.37, issue.3, pp.812-819, 2006. ,
DOI : 10.1161/01.STR.0000204037.26797.7f
HIV-infected patients with lipodystrophy have higher rates of carotid atherosclerosis: The role of monocyte chemoattractant protein-1, Cytokine, vol.34, issue.1-2, 2006. ,
DOI : 10.1016/j.cyto.2006.03.013
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk, Circulation, vol.82, issue.2, pp.495-506, 1990. ,
DOI : 10.1161/01.CIR.82.2.495
Lipodystrophy, Metabolic Disorders, and Human Immunodeficiency Virus Infection: Aquitaine Cohort, France, 1999, Clinical Infectious Diseases, vol.31, issue.6, pp.1482-1489, 1999. ,
DOI : 10.1086/317477
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, vol.92, issue.7, pp.412-419, 1985. ,
DOI : 10.1007/BF00280883
Decrease in LDL size in HIV-positive adults before and after lopinavir/ritonavir-containing regimen: an index of atherogenicity?, Atherosclerosis, vol.168, issue.1, pp.107-120, 2003. ,
DOI : 10.1016/S0021-9150(03)00058-3
Immunoturbidimetric Determination of C-Reactive Protein (CRP) and High-Sensitivity CRP on Heparin Plasma. Comparison with Serum Determination, Clinical Chemistry and Laboratory Medicine, vol.41, issue.7, pp.948-957, 2003. ,
DOI : 10.1515/CCLM.2003.144
Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure, J Immunol, vol.161, pp.2524-2556, 1998. ,
A simple fluorometric assay for lipoperoxide in blood plasma, Biochemical Medicine, vol.15, issue.2, pp.212-216, 1976. ,
DOI : 10.1016/0006-2944(76)90049-1
Advanced glycation end products and mortality in hemodialysis patients, Kidney International, vol.62, issue.1, pp.301-311, 2002. ,
DOI : 10.1046/j.1523-1755.2002.00423.x
The Metabolic Syndrome and Risk of Cardiovascular Disease and Diabetes: Experiences with the New Diagnostic Criteria from the International Diabetes Federation, Hormone and Metabolic Research, vol.39, issue.9, pp.642-50, 2007. ,
DOI : 10.1055/s-2007-985822
Comparison of different definitions of the metabolic syndrome, European Journal of Clinical Investigation, vol.23, issue.2, pp.109-125, 2007. ,
DOI : 10.1001/jama.283.2.221
Metabolic Syndrome and Subclinical Atherosclerosis in Patients Infected with HIV, Clinical Infectious Diseases, vol.44, issue.10, pp.1368-74, 2007. ,
DOI : 10.1086/516616
Carotid Intimal Medial Thickness in Human Immunodeficiency Virus-Infected Women: Effects of Protease Inhibitor Use, Cardiac Risk Factors, and the Metabolic Syndrome, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.12, pp.4916-4940, 2006. ,
DOI : 10.1210/jc.2006-1140
Prevalence of Metabolic Syndrome in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy Using International Diabetes Foundation and Adult Treatment Panel III Criteria: Associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia, Diabetes Care, vol.30, issue.1, pp.113-122, 2007. ,
DOI : 10.2337/dc06-1075
Metabolic Syndrome Among HIV-Infected Patients: Prevalence, characteristics, and related factors, Diabetes Care, vol.28, issue.1, pp.132-139, 2005. ,
DOI : 10.2337/diacare.28.1.132
Incidence of Metabolic Syndrome in a Cohort of HIV-Infected Adults and Prevalence Relative to the US Population (National Health and Nutrition Examination Survey), JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.43, issue.4, pp.458-66, 2006. ,
DOI : 10.1097/01.qai.0000243093.34652.41
Cardiovascular risk markers associated with the metabolic syndrome in a large French population: the SYMFONIE study, Diabetes & Metabolism, vol.32, issue.5, pp.467-7410, 2006. ,
DOI : 10.1016/S1262-3636(07)70305-1
C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study, Circulation, vol.110, issue.4, pp.380-385, 2004. ,
DOI : 10.1161/01.CIR.0000136581.59584.0E
Metabolic Syndrome Is Associated with Elevated Oxidative Stress and Dysfunctional Dense High-Density Lipoprotein Particles Displaying Impaired Antioxidative Activity, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.10, pp.4963-71, 2004. ,
DOI : 10.1210/jc.2004-0305
Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients*, HIV Medicine, vol.8, issue.6, pp.380-387, 2005. ,
DOI : 10.1038/35393
Change in atherosclerosis progression in HIV-infected patients: ANRS Aquitaine Cohort, 1999???2004, AIDS, vol.19, issue.7, pp.729-760, 1999. ,
DOI : 10.1097/01.aids.0000166097.46940.35